Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05619913 |
| Title | EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma (EPOCH) |
| Acronym | EPOCH |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Australia New Zealand Gynaecological Oncology Group |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | GBR | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Prince of Wales Hospital | Randwick | New South Wales | Australia | Details | ||
| Royal Brisbane and Women's Hospital | Herston | Queensland | Australia | Details | ||
| Monash Health | Clayton | Victoria | Australia | Details | ||
| Peter MacCallum Cancer Centre | Melbourne | Victoria | 8006 | Australia | Details | |
| Princess Margaret Hospital | Toronto | Ontario | Canada | Details | ||
| Imperial College London | London | London | United Kingdom | Details |